A significant component of advanced renal cell carcinoma therapy is treatment with tyrosine kinase inhibitors.
Hand-foot syndrome is a frequent adverse reaction and the quality of life of patients can be considerably affected depending on the severity. Effective treatment options are, therefore, essential and standardization of treatment recommendations is desirable. In this article practical and standardized recommendations for the treatment of outpatients with hand-foot syndrome are introduced and several strategies for prophylaxis and therapy are discussed.
Written by:
Burbach GJ, Zuberbier T. Are you the author?
Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universtitätsmedizin Berlin, Campus Mitte, Charitéplatz 1, 10117, Berlin, Deutschland.
Reference: Urologe A. 2013 Jun 6. Epub ahead of print.
doi: 10.1007/s00120-013-3204-7
PubMed Abstract
PMID: 23744244
Article in German.
UroToday.com Renal Cancer Section
